Evidence map›Paper›PMID 24307921›Full record

ArticleThe Journal of clinical and aesthetic dermatology2013

Topical corticosteroid application and the structural and functional integrity of the epidermal barrier.

James Q Del Rosso, Kimberly Cash

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Chronic Hand Eczema (CHE): A Narrative Review.Dermatology and therapy · 2025
    Review
  3. Article
  4. Chronic Hand Eczema.American journal of clinical dermatology · 2024
    Review
  5. Article
  6. Article
  7. A new avenue for treatment of chronic hand eczema.The British journal of dermatology · 2022
    Article
  8. Efinaconazole in Onychomycosis.American journal of clinical dermatology · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Impetiginized Dyshidrotic Eczema.Open access Macedonian journal of medical sciences · 2017
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James Q Del RossoDr. Del Rosso is Adjunct Clinical Professor (Dermatology), Touro University College of Oseopathic Medicine, Henderson, Nevada, and is with the has Vegas Skin and Cancer Clinics/West Dermatology Group, Las Vegas, Nevada. Dr. Cash is Scientific Affairs Consultant, North Carolina.
Kimberly Cash
Touro University Nevada · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topical corticosteroids are a very important part of the treatment of many skin disorders, especially eczematous dermatoses. When utilized properly and judiciously these agents often achieve excellent results in clearing or markedly improving many dermatological disorders. As some studies have shown, topical corticosteroids, despite their ability to decrease inflammation through several mechanisms, induce abnormalities in lipid synthesis and intercellular bilayer structure in the stratum corneum, which appear to prolong epidermal barrier recovery. These adverse effects may contribute to eariier eczematous flaring if measures to provide barrier repair are not undertaken. In addition, although topical corticosteroids are applied only to sites affected by the skin eruption, the incorporation of "barrier friendly" excipients into the vehicle that improve stratum corneum permeability barrier function and integrity is very rational.

Identifiers

PMID24307921
PMCPMC3848648
OpenAlexW2994313209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.